Cargando…

Profile of perampanel and its potential in the treatment of partial onset seizures

Perampanel (PER) is a novel antiepileptic compound that decreases neuronal excitability by modulating glutamatergic transmission through selective noncompetitive blockade of AMPA receptors. PER has been evaluated in three pivotal placebo-controlled randomized trials as adjunctive therapy in adult dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rheims, Sylvain, Ryvlin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663472/
https://www.ncbi.nlm.nih.gov/pubmed/23717043
http://dx.doi.org/10.2147/NDT.S30129